Successful Treatment with Dupilumab in a Patient with Severe, Difficult to Treat Atopic Dermatitis: Beware of Symptomatic Adrenal Insufficiency due to Abrupt Discontinuation of Pot...

by Lieneke F.M. Ariëns, Jorien van der Schaft, Aline M.E. Stades, Anthonie A. van de Woestijne, Marjolein S. De Bruin-Weller
Published 2018-04-01

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment

by Lieneke F.M. Ariëns, Kirsten J.M. van Nimwegen, Marjan Shams, Digna T. de Bruin, Jorien van der Schaft, Harmieke van Os-Medendorp, Marjolein De Bruin-Weller
Published 2019-06-01

Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema

by Floor M. Garritsen, Jorien van der Schaft, Marlies de Graaf, Dirk Jan Hijnen, Carla A.F. Bruijnzeel-Koomen, Marcel P.H. van den Broek, Marjolein S. De Bruin-Weller
Published 2017-12-01

Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs

by Floor M. Garritsen, Jorien van der Schaft, Juul M. Reek, Klaziena Politiek, Harmieke van den Os-Medendorp, Marijke van Dijk, Dirk J. Hijnen, Marlies de Graaf, Carla A. Bruijnzeel-Koomen, Elke M. de Jong, Marie-Louise A. Schuttelaar, Marjolein S. Bruin-Weller
Published 2017-03-01